By reducing FAK signaling pathway activation, VS-4718 lowers fibrosis and immunosuppressive cells and increases pancreatic tumor sensitivity to chemotherapy and immunotherapy (Jiang et al., 2016). This evidence concerns the gene PTK2 and pancreatic neoplasm.